Search

Your search keyword '"Barnaba, V."' showing total 360 results

Search Constraints

Start Over You searched for: Author "Barnaba, V." Remove constraint Author: "Barnaba, V."
360 results on '"Barnaba, V."'

Search Results

2. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)

4. Nuovi sguardi sul vino: linguaggio e personalità

11. Gestione delle emozioni e terremoti

12. Nutlin-3a enhances natural killer cell-mediated killing of neuroblastoma by restoring p53-dependent expression of ligands for NKG2D and DNAM-1 receptors

15. Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma

20. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

23. Fatty acid metabolism complements glycolysis in th selective regulatory t cell expansion during tumor growth

24. Guidelines for the use of flow cytometry and cell sorting in immunological studies

25. Guidelines for the use of flow cytometry and cell sorting in immunological studies

26. Consensus guidelines for the detection of immunogenic cell death

27. Over-expression of miR-223 in T-lymphocytes of early rheumatoid arthritis patients

32. Responses of peptide-specific T cells to stimulation with polystyrene beads carrying HLA class I molecules loaded with single peptides

37. Presence of effector CD8+ T cells in hepatitis C virus-exposed healthy seronegative donors

38. Generation of an MHC class II-restricted T cell epitope by extracellular processing of hepatitis delta antigen

42. Relation between treatment efficacy and cumulative dose of alpha interferon in chronic hepatitis B

43. Two bcr-abl junction peptides bind HLA-A3 molecules and allow specific induction of human cytotoxic T lymphocytes

45. Homing of CD4+CD56+ T lymphocytes into kidney allografts during tubular necrosis or rejection

49. Normalization of depressed natural killer activity after interferon-alpha therapy is associated with a low frequency of relapse in patients with chronic hepatitis C

50. 602 THE CANDIDATE HCV E1E2MF59 VACCINE IS SAFE IN CHRONIC HEPATITIS C PATIENTS AND ACCELLERATES THE SECOND PHASE VIRAL DECLINE UPON PRIMARY RESPONSE TO PEG-INTERFERON-2A/RIBAVIRIN THERAPY

Catalog

Books, media, physical & digital resources